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Abstract - Targeted delivery of pharmaceutical agents to 
the brain using magnetic nanoparticles (MNPs) is an 
efficient technique to transport molecules to disease 
locations. MNPs can cross the blood–brain barrier (BBB) 
and can be concentrated at a specific location in the brain 
using non-invasive electromagnetic forces. The proposed 
EMA consists of two coil-core system. The cores are 
added in the center of each coil to concentrate the flux in 
the region of interest.  The EMA can enhance the gradient 
field 10 times compared to only coil system and generate 
the maximum magnetic field of 160 mT and 5.6 T/m.  A 
12-kW direct-current power supply was used to generate 
sufficient magnetic forces on the MNPs by regulating the 
input currents of the coils. Effective guidance of MNPs is 
demonstrated via simulations and experiments using 
800-nm-diameter MNPs in a Y-shaped channel. The 
developed EMA system has high potentials to increase 
BBB crossing of MNPs for efficient drug targeting to 
brain regions. 
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1. Introduction 
 
Magnetic drugs are pharmaceutical agents combined 
with magnetic particles, and have applications in targeting 
disease locations using externally applied magnetic fields. 
This technique has advantages including avoiding surgery 
and reducing side effects, and can in principle achieve a 
high targeting efficiency. Nanometer-scale magnetic 
particles, or magnetic nanoparticles (MNPs) can be 
biocompatible, soluble, and metabolically stable  [1]. In 
particular, MNPs are suitable for delivering drugs to 
specific locations within the brain, and can cross the blood 
brain barrier (BBB)  [2],  [3]. However, because the 
magnetic force is proportional to the cube of the diameter 
of magnetic particles, the magnetic force on nanoparticles 
is weak, making it challenging to steer MNPs 
magnetically. 
In recent years, actuator systems have been proposed 
for steering magnetic particles or microrobot in blood 
vessels  [4]– [9]. Actuator systems using permanent 
magnets  [4],  [5] are not effective, however, especially for 
steering particles deep inside the body, and 
electromagnetic actuators have been shown to be more 
suitable for targeting particles deep inside bodies  [6]– [9].  
Abbott et. al.  [6] and Han et. al.  [7] proposed using 
electromagnetic actuators for guiding micron-sized 
particles.  Jeon et. al.  [8] and Choi et. al.  [9] also designed 
an intricate actuator system with sets of Helmholtz and 
Maxwell coils. However, it should be noted that, to date, 
the steered particles had diameters of a few to tens of 
microns  [6-10]. In  [11], the authors developed an actuator 
system for manipulating a robot, which contains drugs 
inside and releases the drug at the targeted position. 
However, the size of the robot is about a few millimeters 
and it is not feasible for navigating MNPs in blood vessels 
of a brain.  
Here we describe an electromagnetic steering system 
for controlling MNPs in fluidic environments. The 
proposed EMA consists of two coil-core system. The cores 
are added in the center of each coil to concentrate the flux 
in the region of interest. This actuator system can generate 
a magnetic field gradient of 5.6 T/m. We experimentally 
demonstrate that the electromagnetic system can be used 
to steer 800-nm-diameter MNPs to the correct outlet of a 
Y-shaped fluidic channel.  
 
2. Nanoparticle Steering Method 
 
The motion of the MNP in a viscous fluid is governed 
by the following forces: hydrodynamic drag Fd, the 
magnetic force Fm, the apparent weight of the MNP Wa, 
the contact force Fc, van der Waals forces Fvdw, 
electrostatic forces Fel, and forces due to steric interaction 
Fs. The Newton-Euler equation can be expressed as 
                                     (1) 
where  is the velocity of the MNPs. Arcese et al. 
described mathematical models of each of these forces in 
detail [12]. Compared with the magnitudes of the drag and 
magnetic forces, the remaining five are several orders of 
magnitude weaker and therefore can be neglected [13].  
To steer particles to a desired site through the 
vascular system, a closed-loop control approach is 
desirable, and there have been a number of reports of 
such systems for micron-sized particles  [6],  [7],  [14],  [15]. 
In theory, it is possible for such an approach to achieve 
good performance with only a small tracking error; 
however, this places exacting demands on the control 
components and requires real-time high-quality imaging, 
as well as magnetic/electromagnetic actuators with strong 
magnetic fields that can overcome the drag force due to 
the flow of blood. Unfortunately, the utility of this 
approach for nanoparticles appears to be limited. Cherry 
et al.  [16] suggested that targeted drug delivery via 
steering MNPs using electromagnets is not suitable for 
use of small arteries because it is difficult to control 
particles smaller than 20 µm in diameter. However, by 
changing the control method and designing a suitable 
magnetic actuation system, electromagnets can be used 
for targeted drug delivery in the brain. 
 
 
 
Fig. 1. The principle of the magnetic guidance approach. 
 
Unlike with a closed-loop control approach, in which 
the magnetic/electromagnetic actuators are used as a 
propulsion system, here the actuator is used only to steer 
the direction of the nanoparticles; i.e., the blood flow 
propels the particles and the magnetic force is 
perpendicular to the flow inside the vessel to guide the 
particles to the correct branch by controlling the direction 
of the magnetic force at each bifurcation. Compared with 
the closed-loop control approaches discussed above, this 
method requires a weaker magnetic force because the 
drag force exerted on a particle perpendicular to the blood 
flow is considerably less than the drag force in the flow 
direction. Fig. 1 shows the principle of our approach. 
 
2. Electromagnetic Actuator System 
  
 
Fig. 2. Experimental setup of the proposed electromagnetic 
actuator. 
 
Fig. 2 illustrates the experimental setup of the 
electromagnetic actuator system and its geometry. The 
geometric parameters were optimized via extensive 
simulation studies, which have been reported 
previously  [17]. The proposed electromagnetic actuator 
consists of two Cooper coils and, in each coil, a core is 
added to increase the magnetic field density. Each coil had 
7000 turns with diameter of d = 1.0 mm, and the cores 
were formed of a soft magnetic cobalt–iron alloy 
(Vacoflux 50).  
 
  
 
Fig. 3. Response time of the coil-core system.  
 
  
The magnetic field at the region of interest (ROI) was a 
60-mm diameter at the center of the actuation system, and 
was designed for tests on mice. The magnetic force was 
controlled by regulating the current in the coil using DC 
power supplies.  A current of up to 17 A could be applied 
to the coil-core system, which has a resistance 20 Ω, the 
inductance 0.42 H, and the rated power of DC power 
supply was 6 kW.  Fig. 3 shows the response time of the 
coil-core system with a DC power supply. The 1A input 
current command to the DC power supply is set as a step 
function at 1.797 s. At 2.014 s, the magnetic field response 
at the center of ROI reaches 28.2 mT. It means the 
response time of the system is 0.217 s. This response time 
is mainly affected by the inductance of coil and response 
time of the DC power supply. Although this response time 
is quite slow, it is fast enough for particle guidance 
applications as being presented in the next section. Since 
the proposed actuator has been designed for steering 
MNPs with an open-loop method  [17],  the  direction of 
particle trajectory is only required to be  controlled 
through a non-invasive magnetic force and the nonlinear 
effects of the core can be slight on the nanoparticle 
delivery system. Table 1 lists the relationship between the 
input current and actuator responses (i.e., the magnetic 
field and magnetic field gradient) at the center of ROI. 
  
Table 1 Relationship between the input current and magnetic 
field, and the magnetic field gradient using a single-coil-core 
system at the Center of ROI 
 
Current 
(A) 1 2 3 4 5 6 
B (mT) 28.2 54.1 79.8 106.3 132.6 160.7
∇B (T/m) 0.43 0.92 1.39 1.9 2.4 2.8 
 
 
4. Nanoparticle Steering 
 
To verify the effectiveness of the proposed 
electromagnetic guidance system, we discuss 
experimental results with different magnetic fields. Table 
2 lists the specifications of the MNPs and the experimental 
conditions.  
 
Table 2 . Experimental Conditions for Studies 
  
MNP material Iron powder (Fe) 
MNPs diameter 800 nm 
MNPs purity >99.9% 
Flow velocity 13.3 mm/s 
Diameter of the Y-shaped channel 1.0 mm 
Fluid environment Water 
 
 
Fig. 4. Simulated results of guidance with different currents. 
 
 
 
Fig. 5. Snapshots of the locations of MNPs in the channel at 
various times using the electromagnetic actuator with a current of 
3 A. 
 
 
 
Fig. 6. Experimental results of MNPs guidance using different 
currents. 
 
The experiments were carried out with a constant 
magnetic field and only one coil-core was used to generate 
a unidirectional force. The magnetic field and magnetic 
field gradient associated with each input current are listed 
in Table 2. To evaluate the performance of this steering 
approach, a particle tracking simulation was carried out 
using the same experimental conditions using Comsol 
Multiphysics. The particles were released at the center of 
the channel inlet, and the trajectory was calculated in the 
presence of a magnetic field and drag forces due to the 
fluid flow using the particle-tracking module in Comsol 
Multiphysics. The rates of achieving the correct outlet for 
the 800-nm MNPs in both the simulations and experiments 
are lists in Table III. With no magnetic field, the rate of the 
MNP entering the correct outlet was 50%. We define the 
performance improvement (Per. Im.) when the magnetic 
field was used as follows: 
 
 
  
Table 3 Simulated and measured results of the MNPs guidance 
experiments. 
 
Current 
(A)  
1 2 3 
Simulatio
n 
Correct (%) 59 67 77 
Incorrect (%) 41 33 23 
Experime
nt 
Correct (%) 54 65 74 
Incorrect (%) 46 35 26 
Simulated improvement (%) 18 34 54 
Measured improvement (%) 8 30 48 
  
Table 3 lists the performance improvement in both the 
simulations and experiments. Figs. 4–6 illustrate further 
details of the simulated and experimental results that are 
summarized in Table 3. Fig. 4 shows simulated results of 
guidance with various currents in the coil. Fig. 5 shows 
snapshots of the location of the MNPs in the channel at 
different times using the electromagnetic actuator with a 
current of 3 A. Fig. 6 shows the rate of MNPs exiting via 
the correct outlet for different input currents.  To measure 
the density of the MNPs, centrifuge tubes were used to 
store the MNPs mixed with water at the outlets. The MNPs 
were allowed to settle at the bottom of the tubes (which 
required approximately 5 min), and the water was 
removed.  The remaining MNPs in the tubes were 
transferred to microtubes with a scale to measure the 
quantity of MNPs, as shown in Fig. 6. The measurements 
were repeated to accurately read the scale on the 
microtubes.  
We can see that almost 100% of the particles go into the 
correct outlet around 4.3 seconds but after 4.3 seconds, the 
particles go to both correct and incorrect outlets. This 
phenomenon can be explained due to laminar flow in a 
pipe. The velocity becomes fastest at the center and is 
gradually decreasing to zero at the edges. Therefore, the 
particles at the center are firstly reaching to the bifurcation 
region and they can be easily directed to the correct outlet 
with the magnetic guidance. On the other hand, the 
particles that are closer to the incorrect outlet and far from 
the center reach later at the bifurcation region, they have 
more difficulties to be guided to the correct outlet. That is 
the reason why there is a maximum rate of particles at the 
correct outlet around 4.3 seconds. These trends are 
observed in both the simulation and the experiments (Figs. 
5 and 6). As can be seen from Figs. 4–6, good agreement 
was achieved between the simulations and the 
experimental results. 
 
5. Conclusion and Future Work 
We have described an electromagnetic guidance system 
for MNPs for applications in targeted drug delivery. The 
actuator system includes two coil-core systems, and DC 
power supplies were used to supply electric current to the 
coils. A soft core was placed at the center of the coil to 
increase the magnetic field in the region of interest. The 
experimental results show that the electromagnetic 
actuator was able to efficiently steer 800-nm-diameter 
MNPs in a Y-shaped channel.  
As part of future work, we plan to experimentally 
investigate the factors that affect the performance of the 
MNP guidance system including sticking and 
aggregations of the MNPs, as well as to test the MNP 
guidance using experiments on mice. We also have a plan 
to develop a cooling system in order to mitigate the 
heating problems in the coils and extend the actuator 
system to 2D/ 3D. 
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